Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Oxygenta Pharmaceutical Ltd announced the results of a Postal Ballot conducted via remote e-voting from November 12 to December 11, 2025. The single ordinary resolution sought approval for reclassifying certain persons from the 'Promoter/Promoter Group Category' to the 'Public Category' shareholder category. The resolution was passed with overwhelming support, with 99.98% of votes (2,04,83,791 shares) cast in favour and just 0.02% (3,452 shares) against. The Promoter and Promoter Group, which holds approximately 2.14 crore shares, voted entirely in favour of the resolution. A total of 41 members participated in the voting out of 10,345 shareholders on record date November 7, 2025.
This reclassification will reduce the Promoter/Promoter Group's declared shareholding in the company, shifting those shares into the public category. Shareholders should note the change in promoter classification, which may affect perceptions of promoter control, though the actual ownership of shares remains with the same individuals.